img

Global Bispecific Antibody Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bispecific Antibody Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Bispecific Antibody Drug Market
Global Bispecific Antibody Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Bispecific Antibody Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Bispecific Antibody Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bispecific Antibody Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
Abbvie
Lindis Biotech
MacroGenics
Genmab
Immunocore Limited
Xencor
Merck
Affimed
Alphamab
Akeso
BeiGene
Segment by Type
Fragment-Based
IgG-Based

Segment by Application


Cancer
Haemophilia
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Bispecific Antibody Drug introduction, etc. Bispecific Antibody Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Bispecific Antibody Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific Antibody Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fragment-Based
1.2.3 IgG-Based
1.3 Market by Application
1.3.1 Global Bispecific Antibody Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific Antibody Drug Market Perspective (2018-2029)
2.2 Global Bispecific Antibody Drug Growth Trends by Region
2.2.1 Bispecific Antibody Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bispecific Antibody Drug Historic Market Size by Region (2018-2024)
2.2.3 Bispecific Antibody Drug Forecasted Market Size by Region (2024-2029)
2.3 Bispecific Antibody Drug Market Dynamics
2.3.1 Bispecific Antibody Drug Industry Trends
2.3.2 Bispecific Antibody Drug Market Drivers
2.3.3 Bispecific Antibody Drug Market Challenges
2.3.4 Bispecific Antibody Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bispecific Antibody Drug by Players
3.1.1 Global Bispecific Antibody Drug Revenue by Players (2018-2024)
3.1.2 Global Bispecific Antibody Drug Revenue Market Share by Players (2018-2024)
3.2 Global Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bispecific Antibody Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Bispecific Antibody Drug Market Concentration Ratio
3.4.1 Global Bispecific Antibody Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibody Drug Revenue in 2022
3.5 Global Key Players of Bispecific Antibody Drug Head office and Area Served
3.6 Global Key Players of Bispecific Antibody Drug, Product and Application
3.7 Global Key Players of Bispecific Antibody Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific Antibody Drug Breakdown Data by Type
4.1 Global Bispecific Antibody Drug Historic Market Size by Type (2018-2024)
4.2 Global Bispecific Antibody Drug Forecasted Market Size by Type (2024-2029)
5 Bispecific Antibody Drug Breakdown Data by Application
5.1 Global Bispecific Antibody Drug Historic Market Size by Application (2018-2024)
5.2 Global Bispecific Antibody Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bispecific Antibody Drug Market Size (2018-2029)
6.2 North America Bispecific Antibody Drug Market Size by Type
6.2.1 North America Bispecific Antibody Drug Market Size by Type (2018-2024)
6.2.2 North America Bispecific Antibody Drug Market Size by Type (2024-2029)
6.2.3 North America Bispecific Antibody Drug Market Share by Type (2018-2029)
6.3 North America Bispecific Antibody Drug Market Size by Application
6.3.1 North America Bispecific Antibody Drug Market Size by Application (2018-2024)
6.3.2 North America Bispecific Antibody Drug Market Size by Application (2024-2029)
6.3.3 North America Bispecific Antibody Drug Market Share by Application (2018-2029)
6.4 North America Bispecific Antibody Drug Market Size by Country
6.4.1 North America Bispecific Antibody Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Bispecific Antibody Drug Market Size by Country (2018-2024)
6.4.3 North America Bispecific Antibody Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Bispecific Antibody Drug Market Size (2018-2029)
7.2 Europe Bispecific Antibody Drug Market Size by Type
7.2.1 Europe Bispecific Antibody Drug Market Size by Type (2018-2024)
7.2.2 Europe Bispecific Antibody Drug Market Size by Type (2024-2029)
7.2.3 Europe Bispecific Antibody Drug Market Share by Type (2018-2029)
7.3 Europe Bispecific Antibody Drug Market Size by Application
7.3.1 Europe Bispecific Antibody Drug Market Size by Application (2018-2024)
7.3.2 Europe Bispecific Antibody Drug Market Size by Application (2024-2029)
7.3.3 Europe Bispecific Antibody Drug Market Share by Application (2018-2029)
7.4 Europe Bispecific Antibody Drug Market Size by Country
7.4.1 Europe Bispecific Antibody Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Bispecific Antibody Drug Market Size by Country (2018-2024)
7.4.3 Europe Bispecific Antibody Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bispecific Antibody Drug Market Size (2018-2029)
8.2 China Bispecific Antibody Drug Market Size by Type
8.2.1 China Bispecific Antibody Drug Market Size by Type (2018-2024)
8.2.2 China Bispecific Antibody Drug Market Size by Type (2024-2029)
8.2.3 China Bispecific Antibody Drug Market Share by Type (2018-2029)
8.3 China Bispecific Antibody Drug Market Size by Application
8.3.1 China Bispecific Antibody Drug Market Size by Application (2018-2024)
8.3.2 China Bispecific Antibody Drug Market Size by Application (2024-2029)
8.3.3 China Bispecific Antibody Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bispecific Antibody Drug Market Size (2018-2029)
9.2 Asia Bispecific Antibody Drug Market Size by Type
9.2.1 Asia Bispecific Antibody Drug Market Size by Type (2018-2024)
9.2.2 Asia Bispecific Antibody Drug Market Size by Type (2024-2029)
9.2.3 Asia Bispecific Antibody Drug Market Share by Type (2018-2029)
9.3 Asia Bispecific Antibody Drug Market Size by Application
9.3.1 Asia Bispecific Antibody Drug Market Size by Application (2018-2024)
9.3.2 Asia Bispecific Antibody Drug Market Size by Application (2024-2029)
9.3.3 Asia Bispecific Antibody Drug Market Share by Application (2018-2029)
9.4 Asia Bispecific Antibody Drug Market Size by Region
9.4.1 Asia Bispecific Antibody Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Bispecific Antibody Drug Market Size by Region (2018-2024)
9.4.3 Asia Bispecific Antibody Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Bispecific Antibody Drug Introduction
11.1.4 Roche Revenue in Bispecific Antibody Drug Business (2018-2024)
11.1.5 Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Bispecific Antibody Drug Introduction
11.2.4 Amgen Revenue in Bispecific Antibody Drug Business (2018-2024)
11.2.5 Amgen Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bispecific Antibody Drug Introduction
11.3.4 Sanofi Revenue in Bispecific Antibody Drug Business (2018-2024)
11.3.5 Sanofi Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bispecific Antibody Drug Introduction
11.4.4 Pfizer Revenue in Bispecific Antibody Drug Business (2018-2024)
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Bispecific Antibody Drug Introduction
11.5.4 Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2018-2024)
11.5.5 Johnson & Johnson Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Bispecific Antibody Drug Introduction
11.6.4 AstraZeneca Revenue in Bispecific Antibody Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Bispecific Antibody Drug Introduction
11.7.4 Abbvie Revenue in Bispecific Antibody Drug Business (2018-2024)
11.7.5 Abbvie Recent Developments
11.8 Lindis Biotech
11.8.1 Lindis Biotech Company Details
11.8.2 Lindis Biotech Business Overview
11.8.3 Lindis Biotech Bispecific Antibody Drug Introduction
11.8.4 Lindis Biotech Revenue in Bispecific Antibody Drug Business (2018-2024)
11.8.5 Lindis Biotech Recent Developments
11.9 MacroGenics
11.9.1 MacroGenics Company Details
11.9.2 MacroGenics Business Overview
11.9.3 MacroGenics Bispecific Antibody Drug Introduction
11.9.4 MacroGenics Revenue in Bispecific Antibody Drug Business (2018-2024)
11.9.5 MacroGenics Recent Developments
11.10 Genmab
11.10.1 Genmab Company Details
11.10.2 Genmab Business Overview
11.10.3 Genmab Bispecific Antibody Drug Introduction
11.10.4 Genmab Revenue in Bispecific Antibody Drug Business (2018-2024)
11.10.5 Genmab Recent Developments
11.11 Immunocore Limited
11.11.1 Immunocore Limited Company Details
11.11.2 Immunocore Limited Business Overview
11.11.3 Immunocore Limited Bispecific Antibody Drug Introduction
11.11.4 Immunocore Limited Revenue in Bispecific Antibody Drug Business (2018-2024)
11.11.5 Immunocore Limited Recent Developments
11.12 Xencor
11.12.1 Xencor Company Details
11.12.2 Xencor Business Overview
11.12.3 Xencor Bispecific Antibody Drug Introduction
11.12.4 Xencor Revenue in Bispecific Antibody Drug Business (2018-2024)
11.12.5 Xencor Recent Developments
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Bispecific Antibody Drug Introduction
11.13.4 Merck Revenue in Bispecific Antibody Drug Business (2018-2024)
11.13.5 Merck Recent Developments
11.14 Affimed
11.14.1 Affimed Company Details
11.14.2 Affimed Business Overview
11.14.3 Affimed Bispecific Antibody Drug Introduction
11.14.4 Affimed Revenue in Bispecific Antibody Drug Business (2018-2024)
11.14.5 Affimed Recent Developments
11.15 Alphamab
11.15.1 Alphamab Company Details
11.15.2 Alphamab Business Overview
11.15.3 Alphamab Bispecific Antibody Drug Introduction
11.15.4 Alphamab Revenue in Bispecific Antibody Drug Business (2018-2024)
11.15.5 Alphamab Recent Developments
11.16 Akeso
11.16.1 Akeso Company Details
11.16.2 Akeso Business Overview
11.16.3 Akeso Bispecific Antibody Drug Introduction
11.16.4 Akeso Revenue in Bispecific Antibody Drug Business (2018-2024)
11.16.5 Akeso Recent Developments
11.17 BeiGene
11.17.1 BeiGene Company Details
11.17.2 BeiGene Business Overview
11.17.3 BeiGene Bispecific Antibody Drug Introduction
11.17.4 BeiGene Revenue in Bispecific Antibody Drug Business (2018-2024)
11.17.5 BeiGene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bispecific Antibody Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Fragment-Based
Table 3. Key Players of IgG-Based
Table 4. Global Bispecific Antibody Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Bispecific Antibody Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Bispecific Antibody Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Bispecific Antibody Drug Market Share by Region (2018-2024)
Table 8. Global Bispecific Antibody Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Bispecific Antibody Drug Market Share by Region (2024-2029)
Table 10. Bispecific Antibody Drug Market Trends
Table 11. Bispecific Antibody Drug Market Drivers
Table 12. Bispecific Antibody Drug Market Challenges
Table 13. Bispecific Antibody Drug Market Restraints
Table 14. Global Bispecific Antibody Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Bispecific Antibody Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Bispecific Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2022)
Table 17. Global Bispecific Antibody Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Bispecific Antibody Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Bispecific Antibody Drug, Headquarters and Area Served
Table 20. Global Key Players of Bispecific Antibody Drug, Product and Application
Table 21. Global Key Players of Bispecific Antibody Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Bispecific Antibody Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Bispecific Antibody Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Bispecific Antibody Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Bispecific Antibody Drug Revenue Share by Application (2018-2024)
Table 29. Global Bispecific Antibody Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Bispecific Antibody Drug Revenue Share by Application (2024-2029)
Table 31. North America Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Bispecific Antibody Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Bispecific Antibody Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Bispecific Antibody Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Bispecific Antibody Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Bispecific Antibody Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Bispecific Antibody Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Bispecific Antibody Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Bispecific Antibody Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Bispecific Antibody Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Bispecific Antibody Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Bispecific Antibody Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Bispecific Antibody Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Bispecific Antibody Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Bispecific Antibody Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Bispecific Antibody Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Bispecific Antibody Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Bispecific Antibody Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Bispecific Antibody Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Bispecific Antibody Drug Product
Table 66. Roche Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 67. Roche Recent Developments
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Bispecific Antibody Drug Product
Table 71. Amgen Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 72. Amgen Recent Developments
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Bispecific Antibody Drug Product
Table 76. Sanofi Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 77. Sanofi Recent Developments
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Bispecific Antibody Drug Product
Table 81. Pfizer Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 82. Pfizer Recent Developments
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Bispecific Antibody Drug Product
Table 86. Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 87. Johnson & Johnson Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Bispecific Antibody Drug Product
Table 91. AstraZeneca Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. Abbvie Company Details
Table 94. Abbvie Business Overview
Table 95. Abbvie Bispecific Antibody Drug Product
Table 96. Abbvie Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 97. Abbvie Recent Developments
Table 98. Lindis Biotech Company Details
Table 99. Lindis Biotech Business Overview
Table 100. Lindis Biotech Bispecific Antibody Drug Product
Table 101. Lindis Biotech Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 102. Lindis Biotech Recent Developments
Table 103. MacroGenics Company Details
Table 104. MacroGenics Business Overview
Table 105. MacroGenics Bispecific Antibody Drug Product
Table 106. MacroGenics Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 107. MacroGenics Recent Developments
Table 108. Genmab Company Details
Table 109. Genmab Business Overview
Table 110. Genmab Bispecific Antibody Drug Product
Table 111. Genmab Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 112. Genmab Recent Developments
Table 113. Immunocore Limited Company Details
Table 114. Immunocore Limited Business Overview
Table 115. Immunocore Limited Bispecific Antibody Drug Product
Table 116. Immunocore Limited Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 117. Immunocore Limited Recent Developments
Table 118. Xencor Company Details
Table 119. Xencor Business Overview
Table 120. Xencor Bispecific Antibody Drug Product
Table 121. Xencor Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 122. Xencor Recent Developments
Table 123. Merck Company Details
Table 124. Merck Business Overview
Table 125. Merck Bispecific Antibody Drug Product
Table 126. Merck Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 127. Merck Recent Developments
Table 128. Affimed Company Details
Table 129. Affimed Business Overview
Table 130. Affimed Bispecific Antibody Drug Product
Table 131. Affimed Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 132. Affimed Recent Developments
Table 133. Alphamab Company Details
Table 134. Alphamab Business Overview
Table 135. Alphamab Bispecific Antibody Drug Product
Table 136. Alphamab Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 137. Alphamab Recent Developments
Table 138. Akeso Company Details
Table 139. Akeso Business Overview
Table 140. Akeso Bispecific Antibody Drug Product
Table 141. Akeso Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 142. Akeso Recent Developments
Table 143. BeiGene Company Details
Table 144. BeiGene Business Overview
Table 145. BeiGene Bispecific Antibody Drug Product
Table 146. BeiGene Revenue in Bispecific Antibody Drug Business (2018-2024) & (US$ Million)
Table 147. BeiGene Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bispecific Antibody Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Bispecific Antibody Drug Market Share by Type: 2022 VS 2029
Figure 3. Fragment-Based Features
Figure 4. IgG-Based Features
Figure 5. Global Bispecific Antibody Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Bispecific Antibody Drug Market Share by Application: 2022 VS 2029
Figure 7. Cancer Case Studies
Figure 8. Haemophilia Case Studies
Figure 9. Other Diseases Case Studies
Figure 10. Bispecific Antibody Drug Report Years Considered
Figure 11. Global Bispecific Antibody Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Bispecific Antibody Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Bispecific Antibody Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Bispecific Antibody Drug Market Share by Players in 2022
Figure 15. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Bispecific Antibody Drug Revenue in 2022
Figure 17. North America Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Bispecific Antibody Drug Market Share by Type (2018-2029)
Figure 19. North America Bispecific Antibody Drug Market Share by Application (2018-2029)
Figure 20. North America Bispecific Antibody Drug Market Share by Country (2018-2029)
Figure 21. United States Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Bispecific Antibody Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Bispecific Antibody Drug Market Share by Type (2018-2029)
Figure 25. Europe Bispecific Antibody Drug Market Share by Application (2018-2029)
Figure 26. Europe Bispecific Antibody Drug Market Share by Country (2018-2029)
Figure 27. Germany Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Bispecific Antibody Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Bispecific Antibody Drug Market Share by Type (2018-2029)
Figure 35. China Bispecific Antibody Drug Market Share by Application (2018-2029)
Figure 36. Asia Bispecific Antibody Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Bispecific Antibody Drug Market Share by Type (2018-2029)
Figure 38. Asia Bispecific Antibody Drug Market Share by Application (2018-2029)
Figure 39. Asia Bispecific Antibody Drug Market Share by Region (2018-2029)
Figure 40. Japan Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Bispecific Antibody Drug Market Share by Country (2018-2029)
Figure 50. Brazil Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Bispecific Antibody Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 57. Amgen Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 59. Pfizer Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 61. AstraZeneca Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 62. Abbvie Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 63. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 64. MacroGenics Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 65. Genmab Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 66. Immunocore Limited Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 67. Xencor Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 68. Merck Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 69. Affimed Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 70. Alphamab Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 71. Akeso Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 72. BeiGene Revenue Growth Rate in Bispecific Antibody Drug Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries